Twist Bioscience Raises $37 Million In Oversubscribed Series C Financing

Twist Bioscience, a company focused on synthetic DNA, today announced the completion of a $37 million Series C financing. Led by Illumina, Inc., participants in the round include new investors Fidelity Management and Research Company and Foresite Capital Management LLC, as well as all existing investors including Nick and Joby Pritzker (through their family’s firm Tao Invest), ARCH Venture Partners, Paladin Capital Group, Yuri Milner, and additional strategic corporate and venture investors.

PhishMe Unveils New Security Solution for Enhanced Visibility into Targeted Phishing Attacks

PhishMe® Inc., the leading provider of phishing threat management solutions that empower employees to be a layer of human security sensors against phishing, malware, and drive-by attacks, today introduces PhishMe Triage, a new product offering that gives incident responders the analytics and visibility into email-based attacks occurring against their organizations in near real-time.

ProtectWise Emerges from Stealth with More than $17 Million in Funding to Launch World’s First Cloud Network DVR for Enterprise Security

ProtectWise exits stealth today to launch a breakthrough cloud-based architecture poised to change the landscape of enterprise network security. ProtectWise leverages cloud economies of scale to deliver a subscription-based service that eliminates blind spots in threat detection, ends alarm fatigue by identifying and prioritizing network threats, and delivers faster and more effective incident response.

Paladin Completes Successful Exit of Biofuels Investment

Paladin Capital Group has completed a successful exit of its 49.9% ownership stake in Guardian Lima Holdings, a joint venture of a 60 million gallon per year biofuel production facility located in Lima, Ohio. Paladin’s stake in the joint venture was purchased by Guardian Energy Holdings, the 50.1% owner and strategic partner in the joint venture. With the closing of the transaction, Guardian Energy now owns 100% of the facility.

10X Genomics Closes $55.5 Million Series B Round

10X Genomics, a provider of an innovative genomics platform, today announced that it has raised $55.5 Million in its Series B financing. Foresite Capital Management led the B round and was joined by the Series A lead, Venrock, as well as new and existing investors, including Paladin Capital Group and funds managed by Morgan Stanley Investment Management. To date, the company has raised a total of more than $80M.

The Bot Baseline: Fraud in Digital Advertising

Advertisers will lose $6.3 billion globally to bots in 2015 The ANA partnered with White Ops, a security company with experience eradicating ad fraud on an initiative to determine the level of bot fraud occurring across the digital advertising industry. The ANA...

Page 10 of 16« First...89101112...Last »